CARRIE BLISSENBACH: Open Payments
NPI 1467188003 · WARREN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,048 in 49 payments from 15 companies in 2025. Trend: 2023 $852 · 2024 $1,000 · 2025 $1,048
Food & beverage: $1,048
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 10 | $147 |
| Exeltis, USA Inc. | 6 | $124 |
| Sage Therapeutics, LLC | 5 | $122 |
| Biogen, Inc. | 1 | $120 |
| MILLICENT US INC | 5 | $105 |
| SHIELD THERAPEUTICS INC | 5 | $88 |
| ABBVIE INC. | 4 | $72 |
| Sumitomo Pharma America, Inc. | 3 | $54 |
| Astellas Pharma US Inc | 2 | $47 |
| Organon LLC | 2 | $38 |
Products named: ZURZUVAE, SLYND, ACCRUFER, LILETTA, FEMRING, MYFEMBREE, Veozah, FEMLYV.
Industry payments across OH — which companies pay providers there.
